The knockout of endothelial-specific TMEM16A significantly lowered the systemic blood pressure and ameliorated endothelial dysfunction in angiotensin II-induced hypertension, whereas the overexpression of endothelial-specific TMEM16A resulted in the opposite effects. The gene discussed is ANO1; the disease is hypertensive disorder.